Skip to main content

24-03-2020 | Infection | Podcast | Audio

COVID-19 in people with rheumatic diseases

Speaker: Kevin Winthrop

Kevin Winthrop, from Oregon Health & Science University in Portland, USA, discusses why patients with rheumatic diseases may be vulnerable to COVID-19 and how different treatments may affect the risk for infection and prognosis of the disease (10:31).

March 24 2020: The coronavirus pandemic is affecting all healthcare professionals across the globe. Medicine Matters’ focus, in this difficult time, is the dissemination of the latest data to support you in your research and clinical practice, based on the scientific literature. We will update the information we provide on the site, as the data are published. However, please refer to your own professional and governmental guidelines for the latest guidance in your own country.

Listen below or subscribe to this Podcast on:

Apple Podcasts | SpotifyGoogle Play Music | Stitcher | TuneIn

COVID-19 and rheumatic disease

Access the latest content, covering SARS-CoV-2 infection in patients with rheumatic disease and the repurposing of rheumatology drugs for COVID-19.

Have your say on Medicine Matters

Visit the conference hub

Image Credits